Literature DB >> 20357955

Activation of the ovine hypothalamic-pituitary-adrenal axis and febrile response by interleukin-6: a comparative study with bacterial lipopolysaccharide endotoxin.

Niel A Karrow1, Qiumei You, Carl McNicoll, Jack Hay.   

Abstract

Sheep were subjected to immune challenge with either recombinant human interleukin-6 (rhIL-6; 2.0 microg/kg; n = 5), Escherichia coli lipopolysaccharide (LPS) endotoxin (400 ng/kg; n = 7), or saline (n = 6) to determine if IL-6 activates the febrile and hypothalamic-pituitary-adrenal axis (HPAA) responses in sheep, and to compare these responses with those associated with endotoxemia. Blood was collected over time to measure plasma adrenocorticotropic hormone (ACTH) and serum cortisol concentrations as indicators of HPAA activity. Unlike LPS, rhIL-6 was not pyrogenic in sheep at this challenge dose. In contrast, rhIL-6 elicited ACTH and cortisol responses that peaked earlier than those induced by LPS. These results suggest that this dose of IL-6, alone, is not sufficient to elicit the febrile response in sheep, however, it is a potent activator of the ovine HPAA response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20357955      PMCID: PMC2801308     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  18 in total

1.  Effects of age and pregnancy on the circulatory activin response of sheep to acute inflammatory challenge by lipopolysaccharide.

Authors:  L McClure; A E O'Connor; S Hayward; G Jenkin; D W Walker; D J Phillips
Journal:  J Endocrinol       Date:  2005-04       Impact factor: 4.286

2.  Role of interleukin 6 in fever in rats.

Authors:  L G LeMay; A J Vander; M J Kluger
Journal:  Am J Physiol       Date:  1990-03

3.  Interleukin-6 is pyrogenic but not somnogenic.

Authors:  M Opp; F Obal; A B Cady; L Johannsen; J M Krueger
Journal:  Physiol Behav       Date:  1989-05

4.  Neuromodulation of acute-phase responses to interleukin-6 in guinea pigs.

Authors:  C M Blatteis; N Quan; L Xin; A L Ungar
Journal:  Brain Res Bull       Date:  1990-12       Impact factor: 4.077

5.  Primary bovine hepatocytes in the study of cytokine induced acute-phase protein secretion in vitro.

Authors:  S P Alsemgeest; G A van 't Klooster; A S van Miert; C K Hulskamp-Koch; E Gruys
Journal:  Vet Immunol Immunopathol       Date:  1996-09       Impact factor: 2.046

6.  IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans.

Authors:  Adam Steensberg; Christian P Fischer; Charlotte Keller; Kirsten Møller; Bente Klarlund Pedersen
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-08       Impact factor: 4.310

7.  Interleukin-1 and interleukin-6 act synergistically to stimulate the release of adrenocorticotropic hormone in vivo.

Authors:  R S Perlstein; E H Mougey; W E Jackson; R Neta
Journal:  Lymphokine Cytokine Res       Date:  1991-04

8.  Interleukin-6 is an afferent signal to the hypothalamo-pituitary-adrenal axis during local inflammation in mice.

Authors:  Andrew V Turnbull; Sukhpal Prehar; Adam R Kennedy; Roderick A Little; Stephen J Hopkins
Journal:  Endocrinology       Date:  2003-05       Impact factor: 4.736

Review 9.  Role of the hypothalamic-pituitary-adrenal axis, glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products.

Authors:  Jeanette I Webster; Esther M Sternberg
Journal:  J Endocrinol       Date:  2004-05       Impact factor: 4.286

10.  The role of interleukin-6 in lipopolysaccharide-induced fever by mechanisms independent of prostaglandin E2.

Authors:  Camilla Nilsberth; Louise Elander; Namik Hamzic; Maria Norell; Johanna Lönn; Linda Engström; Anders Blomqvist
Journal:  Endocrinology       Date:  2008-11-20       Impact factor: 4.736

View more
  1 in total

1.  Effects of bacterial lipopolysaccharide injection on white blood cell counts, hematological variables, and serum glucose, insulin, and cortisol concentrations in ewes fed low- or high-protein diets.

Authors:  D T Yates; C A Löest; T T Ross; D M Hallford; B H Carter; S W Limesand
Journal:  J Anim Sci       Date:  2011-07-25       Impact factor: 3.159

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.